Latest Breaking News On - Daniel de boer - Page 3 : comparemela.com

ProQR Experimental RNA Therapeutic for Rare Eye Disease Misses Endpoints in Late-Stage Trial

ProQR Experimental RNA Therapeutic for Rare Eye Disease Misses Endpoints in Late-Stage Trial
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesBenjamin yerxaEuropean unionFoundation fighting blindnessBest corrected visual acuityDaniel de boerFoundation fighting

Outlook dims for ProQR s RNA therapy for vision loss following failure in key test

The lead RNA therapy from ProQR Therapeutics has failed the main and secondary goals of a pivotal study testing it as a treatment for a rare, inherited vision disorder. Despite the disappointing preliminary data, the biotech said it remains confident in the technology that produced the experimental therapy, sepofarsen, and the Phase 2/3 study will continue.

Aniz girachEli lillyMedical officer aniz girachWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup fundingPatient monitoring systemOtion sensorsHealthcare it

The Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment for a potential therapy for USH2A mediated retinitis pigmentosa

/PRNewswire/ For more than ten years, the Usher Syndrome Coalition has been working to build its international "USH Trust" registry in anticipation of the.

Sandy bolanPatient medical community engagementUsher syndrome coalitionDaniel de boerChief executive officerAssociate directorMedical communityExecutive directorUsher syndromeSyndrome coalition

ProQR Appoints Theresa Heggie as Chief Commercial Officer

Senior leader with extensive global rare disease commercialization experienceTop-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for.

Sarah kielyHans vitzthumCherilyn cecchiniExchange commissionBiocryst pharmaceuticalsLifesci communicationsAlnylam pharmaceuticals as senior viceCornell universityTheresa heggieChief commercial officerDaniel de boerSupervisory boardChief executive officerAlnylam pharmaceuticalsSenior vice presidentGlobal commercial operations

ProQR and Lilly collaborate to develop RNA therapeutic

ProQR and Lilly collaborate to develop RNA therapeutic
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Gerard platenburgEli lillyDaniel de boerChief executive officerAdenosine deaminases actingChief innovation officer